View Author
leukemia patient lymphoblastic leukemia rearrangement lymphoblastic study analysis childhood group disease fication treatment relapse target t-all children diagnosis sample infant protocol result blood level rq-pcr strati detection lymphoblastic leukaemia sensitivity figure fusion university table number t-cell velden therapy signi leukemic value mrd levels laboratory marker breakpoint identi cancer ct value dongen van wering van dongen jjm response outcome mll-af prognostic receptor trial germany department month erasmus mc population marrow leukaemia 34+cd induction mrd-hr frequency tcr gene rearrangements immunoglobulin follow-up samples follow-up identi fied van dongen jj interpretation guideline vaccination range point recurrence clonal ampli
10 Most Recent Publications
|
The controversy of varicella vaccination in children with acute lymphoblastic leukemia
(Article)
Caniza, M.A. Hunger, S.P. Liang, D. Ohara, A. Okamura, J. Pieters, R. Schmiegelow, K. Schrappe, M. Stark, B. Stary, J. Schrauder, A. Valsecchi, M.G. Pui, C.H. Masera, G. Baruchel, A. Biondi, A. Devidas, M. Horibe, K. |
2012-01-01
|
|
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study
(Article)
Schrappe, M. Valsecchi, M.G. Reiter, A. Basso, G. Klingebiel, T. Messina, C. Ratei, R. Cazzaniga, G. Koehler, R. Locatelli, F. Schäfer, B.W. Aricò, M. Bartram, C.R. Welte, K. Dongen, J.J.M. van Gadner, H. Biondi, A. Conter, V. Schrauder, A. Panzer-Grümayer, R. Möricke, A. Parasole, R. Zimmermann, M. Dworzak, M.N. Buldini, B. |
2011-08-25
|
|
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: First evidence for genetic predisposition
(Article)
Szczepański, T. Velden, V.H.J. van der Stadt, U.Z. Campana, D. Schrauder, A. Sutton, R. Wering, E.R. van Meijerink, J.P.P. Dongen, J.J.M. van Waanders, E. Kuiper, R.P. Vlierberghe, P. van Gruhn, B. Eckert, C. Panzer-Grümayer, R. Basso, G. Cavé, H. |
2011-04-20
|
|
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFMALL 2000 study
(Article)
Conter, V. Bartram, C.R. Stanulla, M. Locatelli, F. Basso, G. Niggli, F. Barisone, E. Henze, G. Ludwig, W.D. Haas, O.A. Cazzaniga, G. Koehler, R. Valsecchi, M.G. Silvestri, D. Bradtke, J. Parasole, R. Beier, R. Dongen, J.J.M. van Biondi, A. Schrappe, M. Schrauder, A. Panzer-Grümayer, R. Möricke, A. Aricò, M. Zimmermann, M. Mann, G. Rossi, G. de |
2010-04-22
|
|
Standardized MRD quantification in European all trials: Proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
(Article)
Brüggemann, M. Schrauder, A. Biondi, A. Cavé, H. Dombret, H. Fielding, A.K. Foà, R. Gökbuget, N. Goldstone, A.H. Goulden, N. Henze, G. Hoelzer, D. Raff, T. Janka-Schaub, G.E. Macintyre, E. Pieters, R. Rambaldi, A. Ribera, J.M. Schmiegelow, K. Spinelli, O. Stary, J. Stackelberg, A. von Kneba, M. Pfeifer, H. Schrappe, M. Dongen, J.J.M. van Dworzak, M.N. Ottmann, O.G. Asnafi, V. Baruchel, A. Bassan, R. Benoit, Y. |
2010-03-01
|
|
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia
(Article)
Goessel, H. von Jacobs, U. Panzer-Grümayer, E.R. Schrappe, M. Rascher, W. Metzler, M. Semper, S. Krumbholz, M. Langer, T. Keller, T. Schrauder, A. Velden, V.H.J. van der Dongen, J.J.M. van Harbott, J. |
2009-08-01
|
|
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
(Article)
Velden, V.H.J. van der Corral, L. Marschalek, R. Nigro, L.L. Metzler, M. Basso, G. Mann, G. Boer, M.L. den Biondi, A. Pieters, R. Dongen, J.J.M. van Valsecchi, M.G. Jansen, M.W.J.C. Lorenzo, P. de Cazzaniga, G. Panzer-Grumayer, E.R. Schrappe, M. Schrauder, A. Meyer, C. |
2009-02-13
|
|
In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties
(Article)
le Viseur, C. Hotfilder, M. Harbott, J. Jürgens, H. Schrappe, M. Pieters, R. Vormoor, J. Bomken, S. Wilson, K. Röttgers, S. Schrauder, A. Rosemann, A. Irving, J. Stam, R.W. Shultz, L.D. |
2008-07-08
|
|
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
(Article)
Flohr, T. Schrauder, A. Sutton, R. Koehler, R. Zimmermann, M. Valsecchi, M.G. Gadner, H. Masera, G. Schrappe, M. Dongen, J.J.M. van Biondi, A. Bartram, C.R. Cazzaniga, G. Panzer-Grümayer, R. Velden, V.H.J. van der Fischer, S. Stanulla, M. Basso, G. Niggli, F. Schäfer, B.W. |
2008-04-01
|
|
Childhood secondary ALL after ALL treatment
(Article)
Zuna, J. Cavé, H. Boutard, P. Schrauder, A. Sterba, J. Marschalek, R. Dongen, J.J.M. van Hrusak, O. Stary, J. Trka, J. Eckert, C. Szczepański, T. Meyer, C. Mejstříková, E. Fronkova, E. Muzikova, K. Clappier, E. Mendelova, D. |
2007-07-01
|
